Showing results (171-180 of 238) with videos related to

Sort By:
Pageof 24
Gynecologic Oncology|March 17, 2020
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapyMichalis Liontos, Maria Sotiropoulou, Maria Kaparelou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 27, 2012
Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapyKaren Kelly, Christopher G Azzoli, Petr Zatloukal, et al.
BMC Cancer|December 14, 2018
Management of uterine sarcomas and prognostic indicators: real world data from a single-institutionAnastasios Kyriazoglou, Michael Liontos, Dimitrios C Ziogas, et al.
Vaccine|October 23, 2013
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled studyThomas Harrer, Andreas Plettenberg, Keikawus Arastéh, et al.
Anti-Cancer Drugs|February 2, 2023
Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigmAristotelis Bamias, Roubini Zakopoulou, Kimon Tzannis, et al.
Neurology|May 1, 2019
A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathyHanns Lochmüller, Anthony Behin, Yoseph Caraco, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
<i>BRCA1/2</i> Mutation Types Do Not Affect Prognosis in Ovarian Cancer PatientsMichalis Liontos, Eleni Zografos, Panagiotis Zoumpourlis, et al.
Vaccines|September 23, 2022
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted AgentsFlora Zagouri, Alkistis Papatheodoridi, Michalis Liontos, et al.
Cancers|June 10, 2022
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint InhibitionEvangelos Terpos, Michalis Liontos, Oraianthi Fiste, et al.
Breast (Edinburgh, Scotland)|September 4, 2021
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitorsFlora Zagouri, Evangelos Terpos, Oraianthi Fiste, et al.
Pageof 24